Loading…
Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 G298S transgenic mice
Mutations in the genes TARDBP (encoding the TDP-43 protein) and TBK1 can cause familial ALS. Neuronal cytoplasmatic accumulations of the misfolded, hyperphosphorylated RNA-binding protein TDP-43 are the pathological hallmark of most ALS cases and have been suggested to be a key aspect of ALS pathoge...
Saved in:
Published in: | Experimental neurology 2021-01, Vol.335, p.113496 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | 113496 |
container_title | Experimental neurology |
container_volume | 335 |
creator | Sieverding, Kirsten Ulmer, Johannes Bruno, Clara Satoh, Takashi Tsao, William Freischmidt, Axel Akira, Shizuo Wong, Philip C Ludolph, Albert C Danzer, Karin M Lobsiger, Christian S Brenner, David Weishaupt, Jochen H |
description | Mutations in the genes TARDBP (encoding the TDP-43 protein) and TBK1 can cause familial ALS. Neuronal cytoplasmatic accumulations of the misfolded, hyperphosphorylated RNA-binding protein TDP-43 are the pathological hallmark of most ALS cases and have been suggested to be a key aspect of ALS pathogenesis. Pharmacological induction of autophagy has been shown to reduce mutant TDP-43 aggregates and alleviate motor deficits in mice. TBK1 is exemplary for several other ALS genes that regulate autophagy. Consequently, we employed double mutant mice with both a heterozygous Tbk1 deletion and transgenic expression of human TDP-43
to test the hypothesis that impaired autophagy reduces intracellular clearance of an aggregation-prone protein and enhances toxicity of mutant TDP-43. The heterozygous deletion of Tbk1 did not change expression or cellular distribution of TDP-43 protein, motor neuron loss or reactive gliosis in the spinal cord of double-mutant mice at the age of 19 months. However, it aggravated muscle denervation and, albeit to a small and variable degree, motor dysfunction in TDP-43
transgenic mice, as similarly observed in the SOD1
transgenic mouse model for ALS before. Conclusively, our findings suggest that TBK1 mutations can affect the neuromuscular synapse. |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_33038415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33038415</sourcerecordid><originalsourceid>FETCH-pubmed_primary_330384153</originalsourceid><addsrcrecordid>eNqFzrsOgjAUgOHGxAheXsGcFyApFCPM3hhNZCcFDlikLWlpDD69idHZ6V--4Z8RP6QpDaKYUY8sre0opWkc7RfEY4yyJA53PqkzlOI1tdpZqLHHUWgFuoG8fITw1MaisqDQGS2drVzPDXROVR828PGue91OIBTkx2sQM7hEaXKD0XBlW1SiAikqXJN5w3uLm29XZHs-5YcsGFwpsS4GIyQ3U_HbYn_BGxQzQvA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 G298S transgenic mice</title><source>Elsevier</source><creator>Sieverding, Kirsten ; Ulmer, Johannes ; Bruno, Clara ; Satoh, Takashi ; Tsao, William ; Freischmidt, Axel ; Akira, Shizuo ; Wong, Philip C ; Ludolph, Albert C ; Danzer, Karin M ; Lobsiger, Christian S ; Brenner, David ; Weishaupt, Jochen H</creator><creatorcontrib>Sieverding, Kirsten ; Ulmer, Johannes ; Bruno, Clara ; Satoh, Takashi ; Tsao, William ; Freischmidt, Axel ; Akira, Shizuo ; Wong, Philip C ; Ludolph, Albert C ; Danzer, Karin M ; Lobsiger, Christian S ; Brenner, David ; Weishaupt, Jochen H</creatorcontrib><description>Mutations in the genes TARDBP (encoding the TDP-43 protein) and TBK1 can cause familial ALS. Neuronal cytoplasmatic accumulations of the misfolded, hyperphosphorylated RNA-binding protein TDP-43 are the pathological hallmark of most ALS cases and have been suggested to be a key aspect of ALS pathogenesis. Pharmacological induction of autophagy has been shown to reduce mutant TDP-43 aggregates and alleviate motor deficits in mice. TBK1 is exemplary for several other ALS genes that regulate autophagy. Consequently, we employed double mutant mice with both a heterozygous Tbk1 deletion and transgenic expression of human TDP-43
to test the hypothesis that impaired autophagy reduces intracellular clearance of an aggregation-prone protein and enhances toxicity of mutant TDP-43. The heterozygous deletion of Tbk1 did not change expression or cellular distribution of TDP-43 protein, motor neuron loss or reactive gliosis in the spinal cord of double-mutant mice at the age of 19 months. However, it aggravated muscle denervation and, albeit to a small and variable degree, motor dysfunction in TDP-43
transgenic mice, as similarly observed in the SOD1
transgenic mouse model for ALS before. Conclusively, our findings suggest that TBK1 mutations can affect the neuromuscular synapse.</description><identifier>EISSN: 1090-2430</identifier><identifier>PMID: 33038415</identifier><language>eng</language><publisher>United States</publisher><subject>Amyotrophic Lateral Sclerosis - genetics ; Amyotrophic Lateral Sclerosis - pathology ; Animals ; DNA-Binding Proteins - genetics ; Gene Deletion ; Gliosis - genetics ; Humans ; Immunohistochemistry ; Mice ; Mice, Knockout ; Mice, Transgenic ; Motor Neurons - pathology ; Movement Disorders - genetics ; Movement Disorders - pathology ; Muscle Denervation ; Mutation ; Neuromuscular Junction - pathology ; Protein-Serine-Threonine Kinases - genetics ; Spinal Cord - pathology</subject><ispartof>Experimental neurology, 2021-01, Vol.335, p.113496</ispartof><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33038415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sieverding, Kirsten</creatorcontrib><creatorcontrib>Ulmer, Johannes</creatorcontrib><creatorcontrib>Bruno, Clara</creatorcontrib><creatorcontrib>Satoh, Takashi</creatorcontrib><creatorcontrib>Tsao, William</creatorcontrib><creatorcontrib>Freischmidt, Axel</creatorcontrib><creatorcontrib>Akira, Shizuo</creatorcontrib><creatorcontrib>Wong, Philip C</creatorcontrib><creatorcontrib>Ludolph, Albert C</creatorcontrib><creatorcontrib>Danzer, Karin M</creatorcontrib><creatorcontrib>Lobsiger, Christian S</creatorcontrib><creatorcontrib>Brenner, David</creatorcontrib><creatorcontrib>Weishaupt, Jochen H</creatorcontrib><title>Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 G298S transgenic mice</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>Mutations in the genes TARDBP (encoding the TDP-43 protein) and TBK1 can cause familial ALS. Neuronal cytoplasmatic accumulations of the misfolded, hyperphosphorylated RNA-binding protein TDP-43 are the pathological hallmark of most ALS cases and have been suggested to be a key aspect of ALS pathogenesis. Pharmacological induction of autophagy has been shown to reduce mutant TDP-43 aggregates and alleviate motor deficits in mice. TBK1 is exemplary for several other ALS genes that regulate autophagy. Consequently, we employed double mutant mice with both a heterozygous Tbk1 deletion and transgenic expression of human TDP-43
to test the hypothesis that impaired autophagy reduces intracellular clearance of an aggregation-prone protein and enhances toxicity of mutant TDP-43. The heterozygous deletion of Tbk1 did not change expression or cellular distribution of TDP-43 protein, motor neuron loss or reactive gliosis in the spinal cord of double-mutant mice at the age of 19 months. However, it aggravated muscle denervation and, albeit to a small and variable degree, motor dysfunction in TDP-43
transgenic mice, as similarly observed in the SOD1
transgenic mouse model for ALS before. Conclusively, our findings suggest that TBK1 mutations can affect the neuromuscular synapse.</description><subject>Amyotrophic Lateral Sclerosis - genetics</subject><subject>Amyotrophic Lateral Sclerosis - pathology</subject><subject>Animals</subject><subject>DNA-Binding Proteins - genetics</subject><subject>Gene Deletion</subject><subject>Gliosis - genetics</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Motor Neurons - pathology</subject><subject>Movement Disorders - genetics</subject><subject>Movement Disorders - pathology</subject><subject>Muscle Denervation</subject><subject>Mutation</subject><subject>Neuromuscular Junction - pathology</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Spinal Cord - pathology</subject><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFzrsOgjAUgOHGxAheXsGcFyApFCPM3hhNZCcFDlikLWlpDD69idHZ6V--4Z8RP6QpDaKYUY8sre0opWkc7RfEY4yyJA53PqkzlOI1tdpZqLHHUWgFuoG8fITw1MaisqDQGS2drVzPDXROVR828PGue91OIBTkx2sQM7hEaXKD0XBlW1SiAikqXJN5w3uLm29XZHs-5YcsGFwpsS4GIyQ3U_HbYn_BGxQzQvA</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Sieverding, Kirsten</creator><creator>Ulmer, Johannes</creator><creator>Bruno, Clara</creator><creator>Satoh, Takashi</creator><creator>Tsao, William</creator><creator>Freischmidt, Axel</creator><creator>Akira, Shizuo</creator><creator>Wong, Philip C</creator><creator>Ludolph, Albert C</creator><creator>Danzer, Karin M</creator><creator>Lobsiger, Christian S</creator><creator>Brenner, David</creator><creator>Weishaupt, Jochen H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>202101</creationdate><title>Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 G298S transgenic mice</title><author>Sieverding, Kirsten ; Ulmer, Johannes ; Bruno, Clara ; Satoh, Takashi ; Tsao, William ; Freischmidt, Axel ; Akira, Shizuo ; Wong, Philip C ; Ludolph, Albert C ; Danzer, Karin M ; Lobsiger, Christian S ; Brenner, David ; Weishaupt, Jochen H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_330384153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Amyotrophic Lateral Sclerosis - genetics</topic><topic>Amyotrophic Lateral Sclerosis - pathology</topic><topic>Animals</topic><topic>DNA-Binding Proteins - genetics</topic><topic>Gene Deletion</topic><topic>Gliosis - genetics</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Motor Neurons - pathology</topic><topic>Movement Disorders - genetics</topic><topic>Movement Disorders - pathology</topic><topic>Muscle Denervation</topic><topic>Mutation</topic><topic>Neuromuscular Junction - pathology</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Spinal Cord - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sieverding, Kirsten</creatorcontrib><creatorcontrib>Ulmer, Johannes</creatorcontrib><creatorcontrib>Bruno, Clara</creatorcontrib><creatorcontrib>Satoh, Takashi</creatorcontrib><creatorcontrib>Tsao, William</creatorcontrib><creatorcontrib>Freischmidt, Axel</creatorcontrib><creatorcontrib>Akira, Shizuo</creatorcontrib><creatorcontrib>Wong, Philip C</creatorcontrib><creatorcontrib>Ludolph, Albert C</creatorcontrib><creatorcontrib>Danzer, Karin M</creatorcontrib><creatorcontrib>Lobsiger, Christian S</creatorcontrib><creatorcontrib>Brenner, David</creatorcontrib><creatorcontrib>Weishaupt, Jochen H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sieverding, Kirsten</au><au>Ulmer, Johannes</au><au>Bruno, Clara</au><au>Satoh, Takashi</au><au>Tsao, William</au><au>Freischmidt, Axel</au><au>Akira, Shizuo</au><au>Wong, Philip C</au><au>Ludolph, Albert C</au><au>Danzer, Karin M</au><au>Lobsiger, Christian S</au><au>Brenner, David</au><au>Weishaupt, Jochen H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 G298S transgenic mice</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2021-01</date><risdate>2021</risdate><volume>335</volume><spage>113496</spage><pages>113496-</pages><eissn>1090-2430</eissn><abstract>Mutations in the genes TARDBP (encoding the TDP-43 protein) and TBK1 can cause familial ALS. Neuronal cytoplasmatic accumulations of the misfolded, hyperphosphorylated RNA-binding protein TDP-43 are the pathological hallmark of most ALS cases and have been suggested to be a key aspect of ALS pathogenesis. Pharmacological induction of autophagy has been shown to reduce mutant TDP-43 aggregates and alleviate motor deficits in mice. TBK1 is exemplary for several other ALS genes that regulate autophagy. Consequently, we employed double mutant mice with both a heterozygous Tbk1 deletion and transgenic expression of human TDP-43
to test the hypothesis that impaired autophagy reduces intracellular clearance of an aggregation-prone protein and enhances toxicity of mutant TDP-43. The heterozygous deletion of Tbk1 did not change expression or cellular distribution of TDP-43 protein, motor neuron loss or reactive gliosis in the spinal cord of double-mutant mice at the age of 19 months. However, it aggravated muscle denervation and, albeit to a small and variable degree, motor dysfunction in TDP-43
transgenic mice, as similarly observed in the SOD1
transgenic mouse model for ALS before. Conclusively, our findings suggest that TBK1 mutations can affect the neuromuscular synapse.</abstract><cop>United States</cop><pmid>33038415</pmid></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1090-2430 |
ispartof | Experimental neurology, 2021-01, Vol.335, p.113496 |
issn | 1090-2430 |
language | eng |
recordid | cdi_pubmed_primary_33038415 |
source | Elsevier |
subjects | Amyotrophic Lateral Sclerosis - genetics Amyotrophic Lateral Sclerosis - pathology Animals DNA-Binding Proteins - genetics Gene Deletion Gliosis - genetics Humans Immunohistochemistry Mice Mice, Knockout Mice, Transgenic Motor Neurons - pathology Movement Disorders - genetics Movement Disorders - pathology Muscle Denervation Mutation Neuromuscular Junction - pathology Protein-Serine-Threonine Kinases - genetics Spinal Cord - pathology |
title | Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 G298S transgenic mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A38%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemizygous%20deletion%20of%20Tbk1%20worsens%20neuromuscular%20junction%20pathology%20in%20TDP-43%20G298S%20transgenic%20mice&rft.jtitle=Experimental%20neurology&rft.au=Sieverding,%20Kirsten&rft.date=2021-01&rft.volume=335&rft.spage=113496&rft.pages=113496-&rft.eissn=1090-2430&rft_id=info:doi/&rft_dat=%3Cpubmed%3E33038415%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-pubmed_primary_330384153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33038415&rfr_iscdi=true |